A

Amneal Intermediate Inc
NASDAQ:AMRX

Watchlist Manager
Amneal Intermediate Inc
NASDAQ:AMRX
Watchlist
Price: 8.51 USD -0.7% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
Amneal Intermediate Inc?
Write Note

Amneal Intermediate Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Amneal Intermediate Inc
Accrued Liabilities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
A
Amneal Intermediate Inc
NASDAQ:AMRX
Accrued Liabilities
$403.1m
CAGR 3-Years
251%
CAGR 5-Years
0%
CAGR 10-Years
15%
Johnson & Johnson
NYSE:JNJ
Accrued Liabilities
$33.5B
CAGR 3-Years
4%
CAGR 5-Years
8%
CAGR 10-Years
10%
Bristol-Myers Squibb Co
NYSE:BMY
Accrued Liabilities
$11B
CAGR 3-Years
7%
CAGR 5-Years
15%
CAGR 10-Years
14%
Pfizer Inc
NYSE:PFE
Accrued Liabilities
$2.6B
CAGR 3-Years
0%
CAGR 5-Years
-1%
CAGR 10-Years
3%
Merck & Co Inc
NYSE:MRK
Accrued Liabilities
$14B
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
5%
Eli Lilly and Co
NYSE:LLY
Accrued Liabilities
$13.6B
CAGR 3-Years
20%
CAGR 5-Years
20%
CAGR 10-Years
18%

See Also

What is Amneal Intermediate Inc's Accrued Liabilities?
Accrued Liabilities
403.1m USD

Based on the financial report for Dec 31, 2023, Amneal Intermediate Inc's Accrued Liabilities amounts to 403.1m USD.

What is Amneal Intermediate Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
15%

Over the last year, the Accrued Liabilities growth was 3 503%. The average annual Accrued Liabilities growth rates for Amneal Intermediate Inc have been 251% over the past three years , and 15% over the past ten years .

Back to Top